Clinical trial
Evaluation of Chylomicrons Metabolism in Sub-Clinical Atherosclerosis in…
NCT00475826 · University of Sao Paulo, Other · Unknown status
Key facts
| NCT number | NCT00475826 |
|---|---|
| Title | Evaluation of Chylomicrons Metabolism in Sub-Clinical Atherosclerosis in Patients Whit Heterozigous Familial Hypercholesterolemia (FH) Treated With Statin Plus Ezetimibe |
| Official title | Evaluation of Chylomicrons Metabolism in Sub-Clinical Atherosclerosis in Patients Whit Heterozigous Familial Hypercholesterolemia (FH) Treated With Statin Plus Ezetimibe |
| Lead sponsor | University of Sao Paulo, Other |
| Collaborators | Merck Sharp & Dohme LLC Industry |
| Status | Unknown status |
| Study type | Interventional |
| Conditions | Heterozigous Familial Hypercholesterolemia |
| Intervention type | Drug |
| Interventions | Statins and Ezetimibe |
| Start date | Apr 1, 2007 |
| First posted | May 21, 2007 |
| Last update posted | Mar 21, 2008 |
| Countries | Brazil |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: